Burning Rock Biotech Limited (BNR) is priced at $2.19 after the most recent trading session. At the very opening of the session, the stock price was $2.13 and reached a high price of $2.30, prior to closing the session it reached the value of $2.14. The stock touched a low price of $2.10.Recently in News on June 21, 2022, Burning Rock Announces US$10 Million Share Repurchase Program. Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that its board of directors has authorized a share repurchase plan under which the Company may repurchase its Class A ordinary shares in the form of American depositary shares (“ADSs”) with an aggregate value of up to US$10 million during a 12-month period (the “Share Repurchase Program”). You can read further details here
Burning Rock Biotech Limited had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $11.27 on 04/04/22, with the lowest value was $1.74 for the same time period, recorded on 06/13/22.
Burning Rock Biotech Limited (BNR) full year performance was -92.30%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Burning Rock Biotech Limited shares are logging -92.82% during the 52-week period from high price, and 25.86% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.74 and $30.50.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2559245 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Burning Rock Biotech Limited (BNR) recorded performance in the market was -77.54%, having the revenues showcasing -75.79% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 226.28M, as it employees total of 938 workers.
Analysts verdict on Burning Rock Biotech Limited (BNR)
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 6.33, with a change in the price was noted -6.18. In a similar fashion, Burning Rock Biotech Limited posted a movement of -74.82% for the period of last 100 days, recording 468,844 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for BNR is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Burning Rock Biotech Limited (BNR): Technical Analysis
Raw Stochastic average of Burning Rock Biotech Limited in the period of last 50 days is set at 4.66%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 25.95%. In the last 20 days, the company’s Stochastic %K was 23.71% and its Stochastic %D was recorded 19.93%.
Let’s take a glance in the erstwhile performances of Burning Rock Biotech Limited, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -77.54%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -79.62%, alongside a downfall of -92.30% for the period of the last 12 months. The shares increased approximately by 22.29% in the 7-day charts and went up by -30.74% in the period of the last 30 days. Common stock shares were lifted by -75.79% during last recorded quarter.